FORGOT YOUR DETAILS?

LINK Healthcare Partners With Sigma Tau Group For Regional Distribution Rights To Rare Disease Therapeutics • Exclusive agreement to distribute  in selected countries of  Africa, Asia and Australasia:  Oncaspar® for the treatment of acute lymphoblastic leukemia; Adagen® for adenosine deaminase-severe combined immunodeficiency disease and Cystaran™ for ocular cystinosis • Territory rights expanded for Natulan™ for the treatment

TOP